Rythm designs and develops consumer lab testing products including the World's Easiest Blood Test™.
Rythm has raised $31.5M in total funding. The most recent round was Series B. The last funding was announced in June 2026.
Rythm's investors include General Catalyst.
Rythm is headquartered in San Francisco, United States.
Rythm designs and develops consumer lab testing products including the World's Easiest Blood Test™.
Rythm is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rythm — Funding & Investors." VCBacked, June 1, 2026, https://www.vcbacked.co/company/rythm. Accessed August 14, 2026.
VCBacked. (2026). Rythm — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rythm
{{cite web |title=Rythm — Funding & Investors |url=https://www.vcbacked.co/company/rythm |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated